Friday, December 23, 2016 11:39:36 AM
I think it's because they picked a sour lemon in Dan and
his cronies. Too bad for these numerous people who bought the
stock at 75 cents back in 2014 - check page 19 of 24:
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=10305762
Unfortunately for the ALLMers there have been numerous promises
that haven't come to fruition - particularly in far away lands where
the uneducated 'executives' can't even spell the name of a country right.
It looks like the volume has been picking up lately with little
movement in the stock price and no new hot-air press releases.
How long can they keep up the charade?
Probably not too much longer unless they can continue to sell stock
to mom and pop who don't understand anything about the financial
markets and particularly the bioenergy markets. The problem for
these buyers is that it's sort of similar to a ponzi scheme with
a different twist. They keep on selling stock (private
offerings) at lower prices so the ones who bought in higher
are completely screwed. And even the ones who bought in lower
are still screwed because they're locked in while the stock
continues to go lower.
And don't forget, experienced sharks (like JMJ Financial) buy
these private offerings and they know how to win. What they do
is make sure they can convert the stock at discounts to the
current stock price - known as "death spiral financing."
It's just a matter of time until ALLM is completely exposed as
the sham that it is!
Unfortunately, I don't think it's a Merry Christmas for those in
the link above who purchased for 75 cents when they see the
new buyers in the new link below purchasing for 1/3 that price
or lower - check towards the bottom:
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11691251
Recent BIOF News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 02:34:54 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 05:41:18 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 08/17/2023 01:26:03 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 05:43:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM